teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasie dello stomaco - agenti antineoplastici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
citofur
istituto luso farmaco d'italia s.p.a. - tegafur - tegafur
uft
merck serono s.p.a. - tegafur, associazioni - tegafur, associazioni
uft 36cps 100mg 224mg
merck serono spa - tegafur/uracile - capsule - "capsule rigide" 36 capsule in blister pvc/pvdc/al
ancotil soluzione per infusione 1 % (i. v.)
meda pharmaceuticals switzerland gmbh - flucytosinum - soluzione per infusione 1 % (i. v.) - flucytosinum 10 mg, natrii chloridum corresp. natrium 3.17 mg, trometamolum, acidum hydrochloridum 25 per centum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - antifungini - synthetika
brivirac
laboratori guidotti s.p.a. - brivudina - brivudina
zecovir
laboratori guidotti s.p.a. - brivudina - brivudina
brivex compresse
a. menarini gmbh - brivudinum - compresse - brivudinum 125 mg, cellulosum microcristallinum, lactosum monohydricum 37 mg, povidonum k 26-28, magnesii stearas, pro compresso. - l'infezione da herpes - synthetika
brivudina aristo
aristo pharma gmbh - brivudina - brivudina
viruselect
laboratori guidotti s.p.a. - brivudina - brivudina